Talzenna .1 mg/1 (Talazoparib CAPSULE, LIQUID FILLED) .1 mg/1

Talzenna .1 mg/1 is a liquid-filled capsule containing talazoparib, used for targeted therapy. This medication is designed for oral administration and is manufactured by Pfizer Laboratories.

Strength

.1 mg/1

Pack Size

30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0252-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna .1 mg/1 is primarily used in the context of targeted therapy. Talazoparib, the active ingredient, is often explored for its potential in managing certain types of cancer. Patients and healthcare providers may consider Talzenna .1 mg/1 as part of a broader treatment plan, but specific uses should be discussed with a medical professional.

Side Effects

Common effects of Talzenna .1 mg/1 may include gastrointestinal discomfort and fatigue. Some individuals might experience changes in blood cell counts. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Talzenna .1 mg/1 should be handled with care, following the guidelines provided by a healthcare professional. It is crucial to store the medication as directed and to avoid crushing or opening the capsules unless instructed otherwise. Pregnant women or those planning to become pregnant should discuss the use of Talzenna .1 mg/1 with their healthcare provider.

Avoid Interactions

Talzenna .1 mg/1 may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Talzenna .1 mg/1 is used in targeted therapy, often explored for managing certain types of cancer. Specific uses should be discussed with a healthcare provider.

Talzenna .1 mg/1 is designed for oral administration. The capsules should be swallowed whole with water, unless otherwise instructed by a healthcare provider.

Common effects may include gastrointestinal discomfort and fatigue. Some individuals might experience changes in blood cell counts.

Talzenna .1 mg/1 may interact with certain medications. It is important to inform your healthcare provider about all medications you are taking.

Pregnant women or those planning to become pregnant should discuss the use of Talzenna .1 mg/1 with their healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.